KitePod Episode 5: Antibodies Meet AI – The Immunito AI Revolution
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
KitePod Episode 5: Antibodies Meet AI – The Immunito AI Revolution
-
ナレーター：
-
著者：
このコンテンツについて
In this episode of KitePod, we delve into the fascinating world of Immunito AI, a Bengaluru-based TechBio startup that's transforming the landscape of antibody therapy. Founded by the visionary duo Dr. Aridni Shah and Trisha Chatterjee, Immunito AI leverages artificial intelligence to design cutting-edge antibodies tailored for precise and effective treatments.
Discover how their innovative platforms, imDESIGN and imRANK, are redefining traditional drug discovery by reducing development timelines by 60% and significantly cutting costs. From addressing challenges in biotechnology to creating groundbreaking solutions for diseases like cancer and autoimmune disorders, Immunito AI is a beacon of innovation in the biotech industry.
Join us as we explore their journey, challenges, and triumphs, including their $1 million seed funding, global recognitions, and ambitious mission to make antibody therapies accessible worldwide. Tune in to learn how AI and biotechnology are merging to create a future of faster, smarter, and more efficient medical solutions.
🔍 Check out the full article on Venture Kites:
https://venturekites.com/immunito-ai-antibodies-with-a-side-of-artificial-intelligence/
🌍 Discover more startup stories at Venture Kites!
https://venturekites.com/
🤝 Proudly crafted in collaboration with DORK Company.
https://dorkcompany.com/